Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021

被引:8
|
作者
Yang, Hong [1 ]
Qi, Qi [2 ]
Zhang, Yong [3 ]
Wen, Ning [1 ]
Cao, Lei [1 ]
Liu, Yu [2 ]
Fan, Chunxiang [1 ]
Yan, Dongmei [3 ]
Zhu, Xiaoping [2 ]
Hao, Lixin [1 ]
Zhu, Shuangli [3 ]
Ma, Qianli [2 ]
Liu, Jiajie [2 ]
Ma, Chao [1 ]
Nan, Lei [4 ]
Chen, Yong [5 ]
Ma, Xiaozhen [2 ]
Chen, Na [2 ]
Deng, Kun [4 ]
Shao, Ge [6 ]
Ding, Xianxiang [6 ]
An, Zhijie [1 ]
Rodewald, Lance E. [1 ]
Li, Xiaolei [3 ]
Wang, Dongyan [3 ]
Zhu, Hui [3 ]
Wang, Huaqing [1 ]
Feng, Zijian [7 ]
Xu, Wenbo [3 ]
Zhou, Jiushun [2 ]
Yin, Zundong [1 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, 27 Nan Wei Rd, Beijing 100050, Peoples R China
[2] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Peoples R China
[3] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, Beijing, Peoples R China
[4] Liangshan Prefectural Ctr Dis Control & Prevent, Liangshan, Peoples R China
[5] Leibo Cty Ctr Dis Control & Prevent, Liangshan, Peoples R China
[6] Chinese Field Epidemiol Training Program, Beijing, Peoples R China
[7] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China
关键词
IMMUNOGENICITY; OUTBREAK; SAFETY;
D O I
10.1001/jamanetworkopen.2022.49710
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE The Sabin-strain inactivated poliovirus vaccine (IPV) may be a tool for polio outbreak response in certain situations. OBJECTIVE To investigate the response to a type 2 vaccine-derived poliovirus (VDPV2) outbreak. DESIGN, SETTING, AND PARTICIPANTS This case series was conducted in China after a VDPV2 was detected in stool specimens from a child with acute flaccid paralysis (AFP) in Sichuan Province in 2019, 3 years after the global withdrawal of live, attenuated type 2 oral poliovirus vaccine (OPV). Investigation followed National Health Commission and World Health Organization guidance and included searching hospitals for unreported AFP cases; testing stool specimens from the child, his contacts, and local children; enhanced environmental surveillance for VDPV2s in wastewater; and measuring vaccination coverage. Sabin-strain IPV campaigns were conducted in a wide geographic area. MAIN OUTCOMES AND MEASURES Any VDPV2 detection after completion of the supplementary immunization activities. RESULTS A 28-nucleotide-change VDPV2 was isolated from a young boy. Three VDPV2s were detected in healthy children; 2 were contacts of the original child, and none had paralysis. A search of 31 million hospital records found 10 unreported AFP cases; none were polio. No type 2 polioviruses were found in wastewater. Prior to the event, polio vaccine coverage was 65% among children younger than 5 years. Sabin-strain IPV campaigns reached more than 97% of targeted children, administering 1.4 million doses. No transmission source was identified. More than 1 year of enhanced poliovirus environmental and AFP surveillance detected no additional VDPVs. CONCLUSIONS AND RELEVANCE These findings suggest that the circulating VPDV2 outbreak in 2019 was associated with low vaccine coverage. An investigation discovered 3 infected but otherwise healthy children and no evidence of the virus in wastewater. Following Sabin-strain IPV-only campaigns expanding from county to prefecture, the poliovirus was not detected, and the outbreak response was considered by an expert panel and the World Health Organization to have been successful. This success suggests that the Sabin-strain IPV may be a useful tool for responding to circulating VDPV2 outbreaks when high-quality supplementary immunization activities can be conducted and carefully monitored in settings with good sanitation.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Environmental surveillance detects circulating vaccine-derived poliovirus type 2 that was undetected by acute flaccid paralysis surveillance in 2021 in Uganda
    Tushabe, Phionah
    Bwogi, Josephine
    Eliku, James Peter
    Aine, Francis
    Birungi, Molly
    Gaizi, Joseph
    Nakabazzi, Lucy
    Kabaliisa, Theopista
    Turyahabwe, Irene
    Namuwulya, Prossy
    Nanteza, Mary Bridget
    Bukenya, Henry
    Kanyesigye, Christopher
    Katushabe, Edson
    Ampeire, Immaculate
    Kisakye, Annet
    Bakamutumaho, Barnabas
    Byabamazima, Charles R.
    ARCHIVES OF VIROLOGY, 2023, 168 (05)
  • [32] Environmental surveillance detects circulating vaccine-derived poliovirus type 2 that was undetected by acute flaccid paralysis surveillance in 2021 in Uganda
    Phionah Tushabe
    Josephine Bwogi
    James Peter Eliku
    Francis Aine
    Molly Birungi
    Joseph Gaizi
    Lucy Nakabazzi
    Theopista Kabaliisa
    Irene Turyahabwe
    Prossy Namuwulya
    Mary Bridget Nanteza
    Henry Bukenya
    Christopher Kanyesigye
    Edson Katushabe
    Immaculate Ampeire
    Annet Kisakye
    Barnabas Bakamutumaho
    Charles R. Byabamazima
    Archives of Virology, 2023, 168
  • [33] Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017-2021
    Alleman, Mary M.
    Jorba, Jaume
    Riziki, Yogolelo
    Henderson, Elizabeth
    Mwehu, Anicet
    Seakamela, Lerato
    Howard, Wayne
    Mbule, Albert Kadiobo
    Nsamba, Renee Ntumbannji
    Djawe, Kpandja
    Yapi, Moise Desire
    Mengouo, Marcellin Nimpa
    Gumede, Nicksy
    Ndoutabe, Modjirom
    Kfutwah, Anfumbom K. W.
    Senouci, Kamel
    Burns, Cara C.
    VACCINE, 2023, 41 : A35 - A47
  • [34] Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine
    Hotta, Chiemi
    Ogawa, Tomoko
    Shirasawa, Hiroshi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (05) : 1154 - 1159
  • [35] Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020-2021
    Faye, Martin
    Kebe, Ousmane
    Diop, Boly
    Ndiaye, NDack
    Dosseh, Annick
    Sam, Abdoulaye
    Diallo, Aliou
    Dia, Hamet
    Diallo, Jean Pierre
    Dia, Ndongo
    Kiori, Davy Evrard
    Diop, Ousmane Madiagne
    Sall, Amadou Alpha
    Faye, Ousmane
    EMERGING INFECTIOUS DISEASES, 2022, 28 (10) : 2027 - 2034
  • [36] Outbreak of circulating vaccine-derived poliovirus type 2 (cVDPV2) in Indonesia in 2023-2024
    Ashique, Sumel
    Srivastava, Shriyansh
    Sridhar, Sathvik Belagodu
    Kumar, Sachin
    Rahaman, Abdul S. K.
    Hussain, Md Sadique
    Mohanty, Aroop
    Sah, Sanjit
    Mehta, Rachana
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2025, 37 (01):
  • [37] CDC Polio Surge Response to Expanding Outbreaks of Type 2 Circulating Vaccine-Derived Poliovirus - Africa and Philippines, September 2019-March 2020
    Meyer, Erika
    Sikka, Neha
    Durry, Elias
    Datta, Deblina
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (34): : 1182 - 1183
  • [38] Coordinated Response to Imported Vaccine-Derived Poliovirus Infection, Barcelona, Spain, 2019-2020
    Alamo-Junquera, Dolores
    Politi, Julieta
    Simon, Pere
    Dieli-Crimi, Romina
    Borrell, Ricardo Pujol
    Colobran, Roger
    Martinez-Gallo, Monica
    Campins, Magda
    Anton, Andres
    Esperalba, Juliana
    Andres, Cristina
    Codina, Maria Gema
    Polverino, Eva
    Narciso, M. Rosa
    Molinero, Emilia
    Rius, Cristina
    EMERGING INFECTIOUS DISEASES, 2021, 27 (05) : 1513 - 1516
  • [39] Circulating vaccine-derived poliovirus type 2 outbreak 2024: the current public health concerns and management strategies
    Rajbongshi, Anjon
    Malaker, Suprety
    Shandhi, Shoubeho S.
    Islam, Md. R.
    Dewan, Syed M. R.
    INTERNATIONAL JOURNAL OF SURGERY OPEN, 2024, 62 (04) : 460 - 463
  • [40] A circulating vaccine-derived poliovirus type 2 outbreak in a chronic conflict setting: a descriptive epidemiological study in South Sudan – 2020 to 2021
    Ayesheshem Ademe Tegegne
    Atem Nathan Anyuon
    George Awzenio Legge
    Melisachew Adane Ferede
    Zingbondo Isaac
    Kirbak Anthony Laku
    Sibhatu Biadgilign
    Ochan Taban David Kilo
    Fabian Ndenzako
    Ndoutabe Modjirom
    Olushayo Oluseun Olu
    Sylvester Maleghemi
    BMC Infectious Diseases, 23